Avidity Biosciences logo

Avidity Biosciences Share Price Today (NASDAQ: RNA)

Avidity Biosciences share price is $31.35 & ₹2,698.14 as on 15 Jun 2025, 2.30 'hrs' IST

$31.35

-0.79

(-2.46%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Avidity Biosciences share price in Dollar and Rupees. Guide to invest in Avidity Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Avidity Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Avidity Biosciences share price movements

  • Today's Low: $30.99
    Today's High: $31.68

    Day's Volatility :2.18%

  • 52 Weeks Low: $21.51
    52 Weeks High: $56.00

    52 Weeks Volatility :61.59%

Avidity Biosciences (RNA) Returns

PeriodAvidity Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-7.39%
-6.1%
0.0%
6 Months
-6.17%
-3.4%
0.0%
1 Year
-20.88%
-6.7%
0.0%
3 Years
163.06%
11.8%
2.2%

Avidity Biosciences (RNA) Key Statistics

in dollars & INR

Previous Close
$32.14
Open
$31.3
Today's High
$31.68
Today's Low
$30.99
Market Capitalization
$3.9B
Today's Volume
$968.0K
52 Week High
$56.0
52 Week Low
$21.51
Revenue TTM
$8.9M
EBITDA
$-430.3M
Earnings Per Share (EPS)
$-2.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-34.19%

How to invest in Avidity Biosciences Stock (RNA) from India?

It is very easy for Indian residents to invest directly in Avidity Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avidity Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avidity Biosciences or RNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avidity Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avidity Biosciences shares which would translate to 0.027 fractional shares of Avidity Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Avidity Biosciences, in just a few clicks!

Returns in Avidity Biosciences (RNA) for Indian investors in Rupees

The Avidity Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Avidity Biosciences investment value today

Current value as on today

₹82,205

Returns

₹17,795

(-17.79%)

Returns from Avidity Biosciences Stock

₹20,833 (-20.83%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Avidity Biosciences (RNA)

364.71%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Investment in Avidity Biosciences Shares from India has grown by 364.71% over the past 30 days, indicating increased transactional activity.

100%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Search interest for Avidity Biosciences Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Avidity Biosciences

  • Alethea Capital Management, LLC

    0.35%

Analyst Recommendation on Avidity Biosciences

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Avidity Biosciences(by analysts ranked 0 to 5 stars)

Analyst Forecast on Avidity Biosciences Stock (RNA)

What analysts predicted

Upside of 120.73%

Target:

$69.20

Current:

$31.35

Insights on Avidity Biosciences Stock (Ticker Symbol: RNA)

  • Price Movement

    In the last 7 days, RNA stock has moved down by -13.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 2.97M → 1.57M (in $), with an average decrease of 47.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 8 quarters, -47.02M → -115.77M (in $), with an average decrease of 13.9% per quarter
  • RNA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 112.7%
  • Price to Sales

    ForRNA every $1 of sales, investors are willing to pay $429.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.

Avidity Biosciences Technicals Summary

Sell

Neutral

Buy

Avidity Biosciences is currently in a neutral trading position according to technical analysis indicators.

Avidity Biosciences (RNA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Avidity Biosciences Inc logo
3.23%
-6.17%
-20.88%
163.06%
39.8%
Regeneron Pharmaceuticals, Inc. logo
-11.02%
-27.05%
-49.42%
-5.02%
-10.81%
Beone Medicines Ltd logo
18.08%
52.93%
69.2%
101.57%
55.67%
Vertex Pharmaceuticals Incorporated logo
3.86%
-2.68%
-3.83%
81.53%
66.4%
Alnylam Pharmaceuticals, Inc. logo
7.76%
26.01%
95.45%
128.04%
132.45%

Avidity Biosciences Dividend announcements

  • Avidity Biosciences Earnings

    Avidity Biosciences’s price-to-earnings ratio stands at None

About Avidity Biosciences

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stage for the treatment of people with myotonic dystrophy type 1; Delpacibart braxlosiran that is in Phase 1/2 development stage for treating facioscapulohumeral muscular dystrophy; and Delpacibart zotadirsen, which is in the Phase 2 EXPLORE44 open-label extension study for the treatment of Duchenne muscular dystrophy. The company is also developing precision cardiology candidates targeting rare genetic cardiomyopathies, including AOC 1086 for phospholamban cardiomyopathy and AOC 1072 for protein kinase AMP-activated non-catalytic subunit gamma 2 syndrome. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Organization
Avidity Biosciences
Employees
391
CEO
Ms. Sarah Boyce
Industry
Health Technology

Management People of Avidity Biosciences

NameTitle
Dr. Troy Edward Wilson J.D., Ph.D.
Co-Founder & Independent Chairman
Ms. Sarah Boyce
President, CEO & Director
Mr. Michael F. MacLean CPA
Chief Financial Officer
Dr. W. Michael F. Flanagan Ph.D.
Chief Scientific Officer
Mr. John B. Moriarty Jr., ESQ., J.D.
Chief Legal Officer & Corporate Secretary
Ms. Teresa McCarthy
Chief Human Resources Officer
Prof. Mark E. Davis Ph.D.
Scientific Founder, Member of Scientific Advisory Board and Member of Board of Managers
Dr. Frank P. McCormick Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Charles Calderaro III
Chief Technical Officer
Mr. Eric B. Mosbrooker
Chief Commercial Officer

Important FAQs about investing in RNA Stock from India :

Can Indians buy Avidity Biosciences shares?

Yes, Indians can invest in the Avidity Biosciences (RNA) from India.

With INDmoney, you can buy Avidity Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Avidity Biosciences at zero transaction cost.

How can I buy Avidity Biosciences shares from India?

It is very easy to buy Avidity Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avidity Biosciences (RNA) be purchased?

Yes, you can buy fractional shares of Avidity Biosciences with INDmoney app.

What are the documents required to start investing in Avidity Biosciences stocks?

To start investing in Avidity Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Avidity Biosciences share price today?

Avidity Biosciences share price today stands at $31.35, Open: $31.30 ; Previous Close: $32.14 ; High: $31.68 ; Low: $30.99 ; 52 Week High: $56.00 ; 52 Week Low: $21.51.

The stock opens at $31.30, after a closing price of $32.14. The stock reached a daily high of $31.68 and a low of $30.99, with a 52-week high of $56.00 and a 52-week low of $21.51.

What are today’s High and Low prices of Avidity Biosciences Stock (RNA)?

Today’s highest price of Avidity Biosciences (RNA) is $31.68.

Today’s lowest price of Avidity Biosciences (RNA) is $30.99.

What is the 52 Week High and Low Range of Avidity Biosciences Stock (RNA)?

  • 52 Week High

    $56.00

  • 52 Week Low

    $21.51

What are the historical returns of Avidity Biosciences (RNA)?

  • 1 Month Returns

    3.23%

  • 3 Months Returns

    -6.17%

  • 1 Year Returns

    -20.88%

  • 5 Years Returns

    39.8%

What is today's market capitalisation of Avidity Biosciences?

Today's market capitalisation of Avidity Biosciences RNA is 3.9B

Who is the Chief Executive Officer (CEO) of Avidity Biosciences ?

Ms. Sarah Boyce is the current Chief Executive Officer (CEO) of Avidity Biosciences.